Positive results of a single intra-articular injection of VISCO-VET in canine osteoarthritis

March 4th 2021


TheraVet S.A., a pioneering company in the management of osteoarticular diseases in pets, announced today positive results for its study evaluating VISCO-VET, its injectable visco-regenerative gel, in the prevention and treatment of osteoarthritis in a canine model of the disease. Please discover the press release here.